Validation of the Oxford Participation and Activities Questionnaire

References

• World Health OrganisationInternational Classification of Functioning, Disability and HealthGenevaWorld Health Organisation2001
   Google Scholar
• MorleyDDummettSKellyLDawsonJFitzpatrickRJenkinsonCThe Oxford Participation and Activities Questionnaire: study protocolPatient Relat Outcome Meas201351624399888
   PubMedGoogle Scholar
• SalterKJutaiJWTeasellRFoleyNCBitenskyJBayleyMIssues for selection of outcome measures in stroke rehabilitation: ICF ParticipationDisabil Rehabil20052750752816040555
   PubMed Web of Science ®Google Scholar
• SalterKJutaiJWTeasellRFoleyNCBitenskyJBayleyMIssues for selection of outcome measures in stroke rehabilitation: ICF activityDisabil Rehabil20052731534016040533
   PubMed Web of Science ®Google Scholar
• NoonanVKMillerWCNoreauLSCIRE Research TeamA review of instruments assessing participation in persons with spinal cord injurySpinal Cord20094743544619238163
   PubMed Web of Science ®Google Scholar
• MagasiSPostMWA comparative review of contemporary participation measures’ psychometric properties and content coverageArch Phys Med Rehabil2010919 supplS17S2820801275
   PubMed Web of Science ®Google Scholar
• WilkieRJordanJLMullerSNichollsEHealeyELvan der WindtDAMeasures of social function and participation in musculoskeletal populations: impact on participation and autonomy (IPA), Keele assessment of participation (KAP), participation measure for post-acute care (PM-PAC), participation objective, participation subjective (POPS), rating of perceived participation (ROPP), and The Participation ScaleArthritis Care Res201163S11325336
   Web of Science ®Google Scholar
• TseTDouglasJLentinPCareyLMeasuring participation after stroke: a review of frequently used toolsArch Phys Med Rehabil20139417719222982555
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration, Department of Health and Human SciencesGuidance to Industry Patient Reported Outcome Measures Use in Medical Product Development to Support Labelling ClaimsSilver Spring, MDFood and Drug Administration2009
   Google Scholar
• EMAReflection Paper on the Regulatory Guidance for the Use of Health-Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal ProductsEMEA/CHMP/EWP139391/2004LondonEMA2004
   Google Scholar
• KellyLJenkinsonCDummettSDawsonJFitzpatrickRMorleyDDevelopment of the Oxford Participation and Activities Questionnaire: constructing an item poolPatient Relat Outcome Meas2015614515526056503
   PubMedGoogle Scholar
• KellyLDummettSDawsonJFitzpatrickRJenkinsonCMorleyDGenerating items for the Oxford Participation and Activities Questionnaire (Ox-PAQ)Qual Life Res201423S18182
   Google Scholar
• MorleyDDummettSKellyLDawsonJFitzpatrickRJenkinsonCPretesting the Oxford Participation and Activities Questionnaire: results from an expert reviewMov Disord201530S1S419
   Google Scholar
• GordonPHAmyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trialsAging Dis2013429531024124634
   PubMed Web of Science ®Google Scholar
• NoseworthyJLucchinettiMRodriguezMWeinshenkerBGMultiple sclerosisN Engl J Med200034393895211006371
   PubMed Web of Science ®Google Scholar
• WeinshenkerBBassBRiceGThe natural history of multiple sclerosis: a geographically based study. I. Clinical course and disabilityBrain19891121331462917275
   PubMed Web of Science ®Google Scholar
• KremenchutzkyMRiceGPBaskervilleJWingerchukDMEbersGCThe natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the diseaseBrain2006129pt 358459416401620
   PubMed Web of Science ®Google Scholar
• SchapiraAScience, medicine, and the future: Parkinson’s diseaseBMJ19993183113149924061
   PubMed Web of Science ®Google Scholar
• BloemBHausdorffJVisserJGiladiNFalls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomenaMov Disord20041987188415300651
   PubMed Web of Science ®Google Scholar
• WareJEJrSherbourneCDThe MOS 36-item short-form health survey (SF-36) I: conceptual framework and item selectionMed Care1992304734831593914
   PubMed Web of Science ®Google Scholar
• RAND HEALTH [webpage on the Internet]Medical Outcomes Study: 36-Item Short Form Survey Instrument Available from: http://www.rand.org/health/surveys_tools/mos/mos_core_36item_survey.htmlAccessed May 28, 2015
   Google Scholar
• McDowellIGeneral health status and quality of lifeMcDowellIMeasuring Health: A Guide to Rating Scales and Questionnaires3rd edOxfordOxford University Press2006520703
   Google Scholar
• EuroQol GroupEuroQol – a new facility for the measurement of health related quality of lifeHealth Policy19901619920810109801
   PubMed Web of Science ®Google Scholar
• HerdmanMGudexCLloydADevelopment and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Qual Life Res201120101727173621479777
   PubMed Web of Science ®Google Scholar
• Alvarado-BolañosACervantes-ArriagaARodríguez-ViolanteMConvergent validation of EQ-5D-5L in patients with Parkinson’s diseaseJ Neurol Sci20153581–2535726276513
   PubMed Web of Science ®Google Scholar
• KimSHKimHJLeeSIJoMWComparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in KoreaQual Life Res20122161065107321947656
   PubMed Web of Science ®Google Scholar
• KeeleyTAl-JanabiHLorgellyPCoastJA qualitative assessment of the content validity of the ICECAP-A and EQ-5D-5L and their appropriateness for use in health researchPLoS One2013812e8528724367708
   PubMed Web of Science ®Google Scholar
• GolickiDNiewadaMBuczekJValidity of EQ-5D-5L in strokeQual Life Res201524484585025347978
   PubMed Web of Science ®Google Scholar
• JanssenMFPickardASGolickiDMeasurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country studyQual Life Res20132271717172723184421
   PubMed Web of Science ®Google Scholar
• CronbachLJCoefficient alpha and the internal structure of testsPsychometrika195116297334
   Web of Science ®Google Scholar
• ShroutPEFleissJLIntraclass correlations: uses in assessing rater reliabilityPsychol Bull19798642042818839484
   PubMed Web of Science ®Google Scholar
• PearsonKMathematical contributions to the theory of evolution. III. Regression, heredity and panmixiaPhilos Trans R Soc Lond A1896187253318
   Google Scholar
• IBM CorpIBM SPSS Statistics for Windows, Version 20.0Armonk, NYIBM Corp2011
   Google Scholar
• PetoVJenkinsonCFitzpatrickRGreenhallRThe development of a short measure of functioning and well being for individuals with Parkinson’s diseaseQual Life Res199542412487613534
   PubMed Web of Science ®Google Scholar
• JenkinsonCFitzpatrickRPetoVDummettSMorleyDSaundersPThe Parkinson’s Disease Questionnaire: User Manual3rd edOxfordIsis Outcomes2012
   Google Scholar
• KlinePAn Easy Guide to Factor AnalysisLondonRoutledge1994
   Google Scholar
• EstabrooksCASquiresJEHaydukLACummingsGGNortonPGAdvancing the argument for validity of the Alberta Context Tool with healthcare aides in residential long-term careBMC Med Res Methodol20111110721767378
   PubMed Web of Science ®Google Scholar
• Scientific Advisory Committee of the Medical Outcomes TrustAssessing health status and quality of life instruments: attributes and review criteriaQual Life Res20021119320512074258
   PubMed Web of Science ®Google Scholar
• AndrewsFWitheySSocial Indicators of Well-Being: American’s Perceptions of Life QualityNew York, NYPlenum1976
   Google Scholar
• McDowellIThe theoretical and technical foundations of health managementMcDowellIMeasuring Health: A Guide to Rating Scales and Questionnaires3rd edOxfordOxford University Press20061054
   Google Scholar
• BrazierJDeverillMA checklist for judging preference-based measures of health related quality of life: learning from psychometricsHealth Econ19998415110082142
   PubMed Web of Science ®Google Scholar
• MorleyDSelaiCSchragAThompsonAJJahanshahiMRefinement and validation of the Parental Illness Impact ScaleParkinsonism Relat Disord20101618118519939722
   PubMed Web of Science ®Google Scholar
• PapaioannouDBrazierJParryGHow valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic reviewValue Health20111490792021914513
   PubMed Web of Science ®Google Scholar
• MorleyDDummettSKellyLDawsonJJenkinsonCEvaluating the psychometric properties of an e-based version of the 39-item Parkinson’s Disease QuestionnaireHealth Qual Life Outcomes201513525613007
   PubMed Web of Science ®Google Scholar
• RiaziAHobartJCLampingDLUsing the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profilesJ Neurol Neurosurg Psychiatry20037471071412754336
   PubMed Web of Science ®Google Scholar
• MorleyDSelaiCThompsonAQuality of life and psychosocial well-being in people with multiple sclerosis and Parkinson’s diseaseQual Life Res2007A-114 Abstract#1393. [2007 International Society for Quality of Life Research Meeting Abstracts]
   Google Scholar
• RaschGProbabilistic Models for Some Intelligence and Attainment TestsChicagoUniversity of Chicago Press1960
   Google Scholar
• AndrichDRasch Models for MeasurementLondonSage Publications1988
   Google Scholar
• HobartJCanoSRasch analysisJenkinsonCPetersMBrombergMQuality of Life Measurement in Neurodegenerative and Related ConditionsCambridgeCambridge University Press2011147164
   Google Scholar